Swatler Julian, Turos-Korgul Laura, Kozlowska Ewa, Piwocka Katarzyna
Laboratory of Cytometry, Nencki Institute of Experimental Biology, 02-093 Warsaw, Poland.
Department of Immunology, Institute of Functional Biology and Ecology, University of Warsaw, 02-096 Warsaw, Poland.
Cancers (Basel). 2021 Mar 10;13(6):1203. doi: 10.3390/cancers13061203.
Both chronic myeloid leukemia and acute myeloid leukemia evade the immune response during their development and disease progression. As myeloid leukemia cells modify their bone marrow microenvironment, they lead to dysfunction of cytotoxic cells, such as CD8+ T cells or NK cells, simultaneously promoting development of immunosuppressive regulatory T cells and suppressive myeloid cells. This facilitates disease progression, spreading of leukemic blasts outside the bone marrow niche and therapy resistance. The following review focuses on main immunosuppressive features of myeloid leukemias. Firstly, factors derived directly from leukemic cells - inhibitory receptors, soluble factors and extracellular vesicles, are described. Further, we outline function, properties and origin of main immunosuppressive cells - regulatory T cells, myeloid derived suppressor cells and macrophages. Finally, we analyze interplay between recovery of effector immunity and therapeutic modalities, such as tyrosine kinase inhibitors and chemotherapy.
慢性髓系白血病和急性髓系白血病在其发生发展及疾病进展过程中均能逃避免疫反应。随着髓系白血病细胞改变其骨髓微环境,它们会导致细胞毒性细胞(如CD8+T细胞或NK细胞)功能失调,同时促进免疫抑制性调节性T细胞和抑制性髓系细胞的发育。这有利于疾病进展、白血病原始细胞在骨髓龛外扩散以及产生治疗抗性。以下综述聚焦于髓系白血病的主要免疫抑制特征。首先,描述了直接源自白血病细胞的因素——抑制性受体、可溶性因子和细胞外囊泡。此外,我们概述了主要免疫抑制细胞——调节性T细胞、髓系来源的抑制性细胞和巨噬细胞的功能、特性及来源。最后,我们分析了效应器免疫恢复与治疗方式(如酪氨酸激酶抑制剂和化疗)之间的相互作用。